Clinical trial
A Phase I/II Trial of AK112 in Advanced Solid Tumor
NCT04597541 is registered in ClinicalTrials.gov with Akeso as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Trial of AK112 in Advanced Solid Tumor
- Lead sponsor
- Akeso
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 21, 2020
- Completion date
- July 15, 2024
- Enrollment
- 59 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumor, adult